St Johns Wort

St. John’s Wort is an herbal supplement that helps manage mild to moderate depression by inhibiting the reuptake of neurotransmitters like serotonin, dopamine, and norepinephrine, offering a natural alternative to conventional antidepressants with fewer side effects but requiring caution due to significant drug interactions.

Alternative Names: Hypericum perforatum, Goatweed, Klamath weed, Tipton weed, Rosin rose, Hypericum, Johanniskraut

Categories: Herbal Supplement, Antidepressant, Anxiolytic, Neuroprotective

Primary Longevity Benefits


  • Mood regulation
  • Stress reduction
  • Neuroprotection

Secondary Benefits


  • Antiviral properties
  • Anti-inflammatory effects
  • Wound healing
  • Sleep quality improvement

Mechanism of Action


Overview

St. John’s Wort (Hypericum perforatum) exerts its antidepressant and anxiolytic effects through a complex, multi-target mechanism of action that distinguishes it from conventional antidepressants. Rather than acting on a single neurotransmitter system, it affects multiple neurotransmitters and neurochemical pathways simultaneously. The primary active compounds, hyperforin and hypericin, along with several flavonoids and other constituents, work synergistically to modulate neurotransmitter systems, reduce inflammation, protect neurons, and influence hormone regulation.

This multi-target approach may explain both its effectiveness for mild to moderate depression and its broader range of applications beyond mood disorders.

Primary Mechanisms

Neurotransmitter Reuptake Inhibition

Description: St. John’s Wort inhibits the reuptake of multiple neurotransmitters, increasing their availability in synaptic clefts
Specific Actions:
  • Hyperforin inhibits the reuptake of serotonin, norepinephrine, dopamine, GABA, and glutamate by altering sodium gradients rather than directly binding to transporters
  • This broad-spectrum reuptake inhibition differs from conventional antidepressants that typically target specific transporters
  • The effect is dose-dependent and most pronounced for serotonin and norepinephrine
  • This mechanism is similar to but distinct from conventional antidepressants, potentially explaining its effectiveness with fewer side effects

Monoamine Oxidase Inhibition

Description: St. John’s Wort exhibits mild inhibition of monoamine oxidase (MAO), the enzyme that breaks down neurotransmitters
Specific Actions:
  • Hypericin and other constituents show weak MAO-A and MAO-B inhibition in vitro
  • This effect is relatively mild compared to pharmaceutical MAO inhibitors, reducing risk of serious interactions
  • Contributes to increased neurotransmitter levels, particularly serotonin, dopamine, and norepinephrine
  • The MAO inhibition is not considered strong enough to be the primary mechanism but may contribute to overall effects

Gaba Receptor Modulation

Description: St. John’s Wort affects GABA neurotransmission, contributing to anxiolytic effects
Specific Actions:
  • Certain flavonoids in St. John’s Wort bind to GABA-A receptors, enhancing the inhibitory effects of GABA
  • Hyperforin inhibits GABA reuptake, increasing GABA availability in synapses
  • These effects on the GABA system may explain anxiolytic properties and benefits for sleep
  • The GABA effects are more subtle than those of benzodiazepines, explaining the lack of significant sedation or dependence

Glutamate Regulation

Description: St. John’s Wort modulates glutamate, the primary excitatory neurotransmitter in the brain
Specific Actions:
  • Hyperforin inhibits glutamate reuptake, affecting glutamatergic neurotransmission
  • Some constituents may have NMDA receptor antagonist properties
  • This glutamate modulation may contribute to neuroprotective effects
  • Balancing excitatory (glutamate) and inhibitory (GABA) neurotransmission may explain benefits for mood and anxiety

Secondary Mechanisms

Hpa Axis Modulation

Description: St. John’s Wort influences the hypothalamic-pituitary-adrenal (HPA) axis, which regulates stress response
Specific Actions:
  • Normalizes elevated cortisol levels associated with depression and chronic stress
  • Modulates expression of glucocorticoid receptors
  • Affects the release of corticotropin-releasing factor (CRF) from the hypothalamus
  • This mechanism may explain benefits for stress-related conditions and stress-induced depression

Anti Inflammatory Effects

Description: St. John’s Wort exhibits significant anti-inflammatory properties that may contribute to its antidepressant effects
Specific Actions:
  • Inhibits pro-inflammatory cytokines including IL-6, TNF-α, and IL-1β
  • Reduces microglial activation in the brain
  • Hyperforin has been shown to inhibit cyclooxygenase-1 (COX-1) and 5-lipoxygenase, reducing inflammatory mediators
  • Given the emerging role of inflammation in depression, these effects may be significant for its antidepressant action

Neuroprotective Effects

Description: St. John’s Wort protects neurons from damage and may support neuronal health
Specific Actions:
  • Exhibits antioxidant properties, protecting neurons from oxidative stress
  • Flavonoids in St. John’s Wort may enhance brain-derived neurotrophic factor (BDNF) expression
  • Reduces excitotoxicity through glutamate regulation
  • These neuroprotective effects may contribute to long-term benefits and potential applications beyond depression

Circadian Rhythm Regulation

Description: St. John’s Wort may influence circadian rhythms, potentially explaining benefits for seasonal affective disorder
Specific Actions:
  • Hypericin is photosensitive and may mediate light-dependent effects on circadian regulation
  • May influence melatonin production and metabolism
  • Affects expression of clock genes involved in circadian rhythm regulation
  • This mechanism may explain traditional use for seasonal mood disorders and benefits for sleep

Cytochrome P450 Induction

Description: St. John’s Wort induces cytochrome P450 enzymes, affecting drug metabolism
Specific Actions:
  • Hyperforin activates the pregnane X receptor (PXR), leading to induction of CYP3A4, CYP2C9, and other CYP enzymes
  • Increases expression of P-glycoprotein, affecting drug transport
  • This mechanism is responsible for many drug interactions but is not directly related to therapeutic effects
  • The effect is dose-dependent and most pronounced with higher hyperforin content

Key Bioactive Compounds

Hyperforin

Description: Prenylated phloroglucinol derivative considered the primary active compound for antidepressant effects
Specific Actions:
  • Inhibits reuptake of multiple neurotransmitters by modulating sodium gradients
  • Activates TRPC6 channels, affecting calcium signaling
  • Exhibits anti-inflammatory and antibacterial properties
  • Induces cytochrome P450 enzymes through PXR activation
Examples: Typically standardized to 3-5% in commercial extracts; unstable and sensitive to oxidation; higher concentrations associated with stronger antidepressant effects but more drug interactions

Hypericin

Description: Red-pigmented naphthodianthrone that was initially thought to be the primary active compound
Specific Actions:
  • Weak MAO inhibition
  • Photosensitizing properties that may affect circadian rhythms
  • Antiviral and potential anticancer properties
  • Potential effects on dopamine and serotonin receptors
Examples: Typically standardized to 0.3% in commercial extracts; responsible for the photosensitizing effects of St. John’s Wort; used as a marker compound for standardization

Pseudohypericin

Description: Naphthodianthrone similar to hypericin with related biological activities
Specific Actions:
  • Similar to hypericin but with some distinct pharmacological properties
  • Photosensitizing effects
  • Potential antiviral activity
  • Contributes to overall effects of the herb
Examples: Present in varying amounts depending on growing conditions and extraction methods; contributes to the red color of extracts

Flavonoids

Description: Group of compounds including quercetin, rutin, hyperoside, and others with various biological activities
Specific Actions:
  • Antioxidant and neuroprotective effects
  • Some bind to GABA-A receptors, contributing to anxiolytic effects
  • Anti-inflammatory properties
  • Synergistic effects with other compounds
Examples: Comprise up to 12% of dry weight; contribute significantly to the overall effects of the herb; may enhance the effects of hyperforin and hypericin

Xanthones

Description: Group of compounds with MAO inhibitory and other neurological effects
Specific Actions:
  • More potent MAO inhibition than hypericin
  • Potential neuroprotective effects
  • May affect serotonergic and dopaminergic systems
  • Contribute to overall antidepressant effects
Examples: Present in smaller amounts than other compounds; contribute to the complex pharmacology of the herb

Procyanidins

Description: Oligomeric flavonoids with antioxidant and other biological activities
Specific Actions:
  • Potent antioxidant effects
  • Anti-inflammatory properties
  • May enhance blood-brain barrier penetration of other compounds
  • Contribute to overall neuroprotective effects
Examples: Present in significant amounts in the plant; contribute to the complex pharmacology and synergistic effects

Molecular Targets

Target Interaction Outcome
Neurotransmitter transporters (SERT, NET, DAT) Hyperforin inhibits multiple transporters by altering sodium gradients rather than direct binding Increased synaptic levels of serotonin, norepinephrine, and dopamine, contributing to antidepressant effects
GABA transporters Hyperforin inhibits GABA reuptake Increased GABA levels contributing to anxiolytic effects
GABA-A receptors Certain flavonoids bind to GABA-A receptors Enhanced GABA signaling, contributing to anxiolytic effects
Monoamine oxidase (MAO-A and MAO-B) Hypericin and xanthones weakly inhibit MAO enzymes Reduced breakdown of neurotransmitters, contributing to increased levels
TRPC6 channels Hyperforin activates TRPC6 channels Altered calcium signaling affecting neuronal function and potentially neuroplasticity
Pregnane X receptor (PXR) Hyperforin activates PXR Induction of cytochrome P450 enzymes and P-glycoprotein, leading to drug interactions
Inflammatory mediators (IL-6, TNF-α, IL-1β) Multiple compounds inhibit production of pro-inflammatory cytokines Reduced neuroinflammation, potentially contributing to antidepressant effects
Glutamate transporters Hyperforin inhibits glutamate reuptake Modulation of glutamatergic neurotransmission, affecting mood and neuroplasticity

Synergistic Effects

Compound Interactions

Description: Multiple compounds in St. John’s Wort work together to produce effects greater than any single compound
Specific Synergies:
  • Hyperforin’s neurotransmitter reuptake inhibition combined with hypericin’s MAO inhibition provides complementary effects on neurotransmitter levels
  • Flavonoids enhance the effects of hyperforin and hypericin through antioxidant and anti-inflammatory mechanisms
  • Procyanidins may enhance bioavailability and blood-brain barrier penetration of other compounds
  • The combination of compounds affecting different aspects of depression pathophysiology (neurotransmitters, inflammation, HPA axis) provides a multi-target approach

Multi System Approach

Description: St. John’s Wort affects multiple physiological systems relevant to depression and mood disorders
Specific Examples:
  • Combined effects on neurotransmitter systems (serotonin, norepinephrine, dopamine, GABA) provide comprehensive modulation of mood pathways
  • Simultaneous effects on neuroinflammation and neurotransmission address multiple aspects of depression pathophysiology
  • HPA axis modulation combined with neurotransmitter effects addresses both stress response and mood regulation
  • This multi-system approach may explain effectiveness for conditions with complex pathophysiology

Comparative Mechanisms

Vs Ssris

Similarities:
  • Both increase serotonin levels in synapses
  • Both have delayed onset of full therapeutic effect (2-4 weeks)
  • Both can be effective for depression and anxiety
Differences:
  • St. John’s Wort affects multiple neurotransmitters beyond serotonin
  • SSRIs directly bind to and inhibit the serotonin transporter, while hyperforin alters sodium gradients
  • St. John’s Wort has additional anti-inflammatory and neuroprotective effects not present with SSRIs
  • St. John’s Wort typically has fewer sexual side effects and less emotional blunting than SSRIs

Vs Snris

Similarities:
  • Both affect serotonin and norepinephrine systems
  • Both can be effective for depression with fatigue and low motivation
  • Both have effects on pain perception
Differences:
  • St. John’s Wort affects additional neurotransmitters including dopamine and GABA
  • SNRIs directly bind to transporters, while St. John’s Wort uses a different mechanism
  • St. John’s Wort has additional anti-inflammatory effects not present with SNRIs
  • St. John’s Wort typically has fewer side effects like blood pressure changes and sweating

Vs Tricyclic Antidepressants

Similarities:
  • Both affect multiple neurotransmitter systems
  • Both have been used for various pain conditions
  • Both can improve sleep in some individuals
Differences:
  • Tricyclics have stronger anticholinergic effects leading to more side effects
  • St. John’s Wort has a better safety profile with less cardiotoxicity
  • St. John’s Wort has additional anti-inflammatory mechanisms
  • Tricyclics generally have stronger effects and may be more suitable for severe depression

Vs Mao Inhibitors

Similarities:
  • Both have some degree of MAO inhibition
  • Both can affect multiple neurotransmitter systems
  • Both can be effective for atypical depression
Differences:
  • St. John’s Wort has much weaker MAO inhibition, reducing risk of hypertensive crisis
  • St. John’s Wort does not require dietary restrictions like pharmaceutical MAOIs
  • St. John’s Wort’s primary mechanism is neurotransmitter reuptake inhibition rather than MAO inhibition
  • Pharmaceutical MAOIs are generally more potent for severe or treatment-resistant depression

Time Course Of Action

Acute Effects

  • Some mild effects may begin within hours, particularly for anxiety and sleep
  • Acute effects typically peak within 2-3 days of regular use
  • Effects last as long as adequate levels are maintained; half-life of hyperforin is approximately 9 hours
  • Individual metabolism, extract quality, hyperforin content, and concurrent medications all affect timing

Chronic Effects

  • Full antidepressant effects typically require 2-4 weeks of regular use, similar to conventional antidepressants
  • No significant tolerance development reported with continued use
  • Effects maintained with continued use; some studies suggest continued improvement for up to 6 months
  • Gradual tapering recommended after long-term use; withdrawal effects are generally mild compared to conventional antidepressants

Pharmacodynamic Interactions

With Serotonergic Agents

Description: Potential additive effects with other substances that affect serotonin levels
Examples:
  • SSRIs: Risk of serotonin syndrome due to additive serotonergic effects
  • Triptans: Potential increased risk of serotonin syndrome
  • MAO inhibitors: Significant risk of serotonin syndrome; combination contraindicated
  • Tramadol, dextromethorphan, and other serotonergic medications: Increased risk of serotonin effects

With Hormonal Medications

Description: Potential interactions due to effects on hormone metabolism
Examples:
  • Oral contraceptives: Reduced efficacy due to increased metabolism via CYP3A4 induction
  • Hormone replacement therapy: Potentially reduced effectiveness
  • Thyroid medications: Potential altered metabolism
  • These interactions primarily result from pharmacokinetic effects rather than direct pharmacodynamic interactions

With Immunosuppressants

Description: Potential interactions affecting immunosuppressant efficacy
Examples:
  • Cyclosporine: Significantly reduced blood levels due to CYP3A4 induction
  • Tacrolimus: Reduced effectiveness due to increased metabolism
  • These interactions are primarily pharmacokinetic but have significant clinical implications
  • Combination generally contraindicated in transplant recipients

With Anticoagulants

Description: Potential interactions affecting bleeding risk
Examples:
  • Warfarin: Reduced anticoagulant effect due to increased metabolism
  • Direct oral anticoagulants: Potentially reduced effectiveness
  • These interactions primarily result from pharmacokinetic effects
  • Combination requires careful monitoring of coagulation parameters

Effects On Physiological Systems

Nervous System

Description: Primary site of action for St. John’s Wort’s psychoactive effects
Specific Actions:
  • Modulation of neurotransmitter systems affecting mood, anxiety, and cognition
  • Neuroprotective effects through antioxidant and anti-inflammatory mechanisms
  • Potential enhancement of neuroplasticity through BDNF and related pathways
  • Effects on sleep architecture and circadian rhythms

Endocrine System

Description: Effects on hormone regulation and stress response systems
Specific Actions:
  • Modulation of HPA axis function and cortisol levels
  • Potential effects on thyroid hormone metabolism
  • Influences on sex hormone metabolism through cytochrome P450 induction
  • These effects may contribute to benefits for stress-related conditions and hormonal balance

Immune System

Description: Immunomodulatory effects that may contribute to antidepressant action
Specific Actions:
  • Reduction of pro-inflammatory cytokines implicated in depression
  • Modulation of microglial activation in the brain
  • Antiviral properties, particularly against enveloped viruses
  • These immune effects connect to the inflammatory hypothesis of depression

Digestive System

Description: Traditional use for digestive complaints has some scientific basis
Specific Actions:
  • Anti-inflammatory effects on gastrointestinal tract
  • Traditional use for liver complaints may relate to effects on liver enzymes
  • Antibacterial properties may affect gut microbiota
  • These effects are generally secondary to neuropsychiatric applications in modern use

Mechanism Variations By Preparation

Low Hyperforin Extracts

  • Lower hyperforin content (< 1%) with standard hypericin levels
  • Reduced hyperforin extraction
  • Relatively more influence from hypericin, flavonoids, and other compounds; less pronounced neurotransmitter reuptake inhibition
  • Potentially less effective for depression but fewer drug interactions due to reduced CYP induction; may still be effective for mild cases

High Hyperforin Extracts

  • Higher hyperforin content (3-5%) with standard hypericin levels
  • Minimal; good extraction of most active compounds
  • Strong neurotransmitter reuptake inhibition; pronounced effects on all primary mechanisms
  • More effective for depression but more significant drug interactions due to CYP induction; requires more caution with concomitant medications

Traditional Hydroalcoholic Extracts

  • Balanced extraction of both water-soluble and lipophilic compounds
  • Minimal; good extraction of most active compounds
  • Balanced effects representing the full spectrum of the herb’s activity
  • Traditional preparation with established efficacy; variable hyperforin content depending on specific extraction parameters

Hypericin Standardized Extracts

  • Standardized to hypericin content (typically 0.3%) with variable hyperforin
  • May have reduced hyperforin depending on extraction method
  • Variable depending on actual hyperforin content, which is often not specified
  • Standardization to hypericin alone is insufficient to predict efficacy or drug interaction potential; hyperforin content should also be specified

Fresh Plant Tinctures

  • Fresh plant extraction may preserve some compounds lost in dried preparations
  • Variable depending on specific extraction parameters
  • May have unique profile due to preservation of unstable compounds
  • Traditional preparation with potentially different profile than dried extracts; less commonly used in clinical studies

Plant Part Variations

Flowering Tops

  • Highest concentration of hypericin, hyperforin, and flavonoids; traditional part used
  • Full spectrum of effects as described above
  • Most commonly used part with established efficacy for depression and anxiety
  • Standard safety profile as described in clinical studies

Leaves

  • Lower concentrations of active compounds compared to flowering tops
  • Similar but less potent than flowering tops
  • Less commonly used alone; often included with flowering tops in whole plant preparations
  • Similar to flowering tops but with potentially reduced efficacy and drug interactions

Stems

  • Significantly lower concentrations of active compounds
  • Minimal activity compared to flowering tops
  • Not traditionally used alone; may dilute potency when included in whole plant preparations
  • Lower efficacy; high stem content may indicate poor quality product

Roots

  • Different compound profile with unique xanthones and other constituents
  • Potentially different mechanism profile with more emphasis on MAO inhibition
  • Not traditionally used for depression; some traditional use for other conditions
  • Less research on safety profile; not typically included in commercial preparations

Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a healthcare professional before starting any supplement regimen, especially if you have pre-existing health conditions or are taking medications.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top